| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.8M | +0.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | -100.0% |
| R&D Expense | $47.5M | +4.1% |
| SG&A Expense | $41.6M | -13.9% |
| Interest Expense | $4.5M | +2150.0% |
| Pre-tax Income | -$221.0M | -115.6% |
| Income Tax | $1.7M | +172.4% |
| Net Income | -$87.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $85.6M | -64.1% |
| Short-term Investments | $69.7M | -69.8% |
| Current Assets | $106.9M | -60.2% |
| Total Assets | $360.9M | -17.7% |
| Current Liabilities | $46.2M | +66.3% |
| Long-term Debt | $59.3M | +1145.3% |
| Total Liabilities | $147.3M | +87.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$148.9M | +4.8% |
| Capital Expenditures | $118.8M | +291.9% |
| Investing Cash Flow | -$118.8M | -278.9% |
| Financing Cash Flow | $116.7M | +14.1% |
| Free Cash Flow | -$267.7M | -43.3% |
| -176.7% |
| Stockholders' Equity |
| $213.6M |
| -40.6% |